Nieves Martinez-Chanza

5PUBLICATIONS
16CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 30, 2026
Case report: Tuberculosis versus immune-related bronchiolitis under immune checkpoint inhibitor - a diagnostic challenge.

|Sep 14, 2022
CAR-T Cell Therapy for Solid Tumors: Are we Still That Far? a Systematic Review of Literature.

Aya Karam, Georges Mjaess, Nieves Martinez Chanza

|Dec 03, 2021
Avelumab as neoadjuvant therapy in patients with urothelial non-metastatic muscle invasive bladder cancer: a multicenter, randomized, non-comparative, phase II study (Oncodistinct 004 - AURA trial).

Nieves Martinez Chanza, Louisa Soukane, Philippe Barthelemy

|Nov 12, 2020
Prognostic significance and immune correlates of CD73 expression in renal cell carcinoma.

Abhishek Tripathi, Edwin Lin, Wanling Xie

|Mar 29, 2020
Safety and efficacy of immune checkpoint inhibitors in advanced urological cancers with pre-existing autoimmune disorders: a retrospective international multicenter study.

Nieves Martinez Chanza, Wanling Xie, Majd Issa

Pageof 1

Frequent Collaborators

2 joint publications

Abhishek Tripathi

2 joint publications

Toni K Choueiri

2 joint publications

Lauren C Harshman

1 joint publications

Amin H Nassar